Scott Goedeke is Founder and Partner of Sentero Partners and a commercial leader who has guided pharmaceutical products through every stage of their lifecycle, from pre-launch market analysis and strategic planning through launch execution and mature brand management. His career spans a high-growth specialty pharmaceutical company, a global pharmaceutical company, and pharmaceutical and biotech consulting. He has led teams that launched six new brands, including a specialty injectable orphan drug, and designed and implemented a dedicated specialty distribution network of specialty pharmacies, specialty distributors, and a patient care hub.

Scott has evaluated dozens of business development opportunities that resulted in five acquisitions, and his consulting work has given him deep insight into dozens of therapeutic areas, including rare and orphan diseases. He brings that commercial perspective to First Ascent’s work with pharmaceutical and biotech partners, helping turn functional precision medicine into partnerships that get better treatments to patients sooner.